Biotechnology
LiveSpo Pharma Emerges as Vietnam's Pioneer at Vitafoods Europe 2024, Unveiling Groundbreaking Research and Product Development to Reduce Antibiotic Use in Digestive and Respiratory Care
HANOI, Vietnam, May 17, 2024 /PRNewswire/ -- LiveSpo Pharma is the first Vietnamese entity to report on clinical studies at Vitafoods Europe 2024, held inGeneva, Switzerland. LiveSpo Pharma showcased its range of high-concentration, multi-strain liquid medical probiotics products, affirming the ...
2024-05-17 18:33
4680
Celltrion USA announces two-year data for ZYMFENTRA™(infliximab-dyyb) to be presented at Digestive Disease Week (DDW) 2024 Conference
* Data presentations including the extended LIBERTY studies to highlight the long-term treatment goals ofZYMFENTRA™, the first and only FDA-approved subcutaneous infliximab * The data underscores Celltrion's commitment to improving patient outcomes and advancing scientific understanding in th...
2024-05-17 12:01
1564
Troy Animal Healthcare Strengthens Quality Operations with Veeva Vault Quality
Australian animal health leader adopts Veeva Vault QualityDocs and Veeva Vault
Training for greater efficiency and compliance
SYDNEY, May 17, 2024 /PRNewswire/ -- Troy Animal Healthcare and Veeva Systems
2024-05-17 07:00
16004
Seegene and Springer Nature Announce Strategic Alliance
- Strategic alliance aims to foster collaboration with researchers working in various disease fields by using best-in-class PCR diagnostic technology - Companies will facilitate C-level cooperation, strengthening the partnership for the SG OneSystem™ business (Seegene's technology-sharing busine...
2024-05-16 21:00
2965
Visionary Has World-Class Biochip Technology Products
TORONTO, May 16, 2024 /PRNewswire/ -- Visionary Holdings Inc. (the "Company") (NASDAQ: GV), a private education provider with technology of artificial intelligence and life science on the cutting edge, with subsidiaries inCanada and market partners inChina, today announced the Company has coopera...
2024-05-16 20:30
3094
HSA approves GSK's Arexvy, the world's first respiratory syncytial virus (RSV) vaccine for older adults [1]
* Arexvy has been approved by the Health Sciences Authority (HSA) of Singapore for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older.[2] * Arexvy is 94.6% efficacious in prevent...
2024-05-16 10:00
2161
![HSA approves GSK's Arexvy, the world's first respiratory syncytial virus (RSV) vaccine for older adults [1]](https://mma.prnasia.com/media2/2412228/GSK_Asia_House_Singapore.jpg?p=medium600)
EHA 2024 | Results from Five Studies of Ascentage Pharma's Key Drug Candidates Selected for Presentations at 2024 European Hematology Association Hybrid Congress
SUZHOU, China and ROCKVILLE, Md., May 15, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that the latest results from five studies have been ...
2024-05-16 09:03
1707
/DISREGARD RELEASE: Visionary Holdings Inc./
We are advised by Visionary Holdings Inc. that journalists and other readers should disregard the news release, Celebration of GV's Second Anniversary Listing-GV Anticipates a New Journey, issued14-May-2024 over PR Newswire. ...
2024-05-15 23:01
4391
Ractigen Therapeutics Receives IND Approval from China's NMPA to Initiate Phase 1 Clinical Trials for RAG-17 in SOD1-ALS Patients
SUZHOU, China, May 15, 2024 /PRNewswire/ -- Ractigen Therapeutics, a clinical-stage pharmaceutical company committed to developing pioneering therapies, today announces that the Center for Drug Evaluation (CDE) ofChina's National Medical Products Administration (NMPA) has approved the Investigat...
2024-05-15 20:00
1664
Everest Medicines Announces Commercial Launch and First Prescription for NEFECON® in Mainland China
SHANGHAI, May 14, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative medicines and vaccines, today announced that NEFECON®, a delayed rel...
2024-05-14 21:41
2362
HealthTech Bioactives Partners with Abolis for Sustainable Production of High-Value Polyphenols
PARIS, May 14, 2024 /PRNewswire/ -- HealthTech Bioactives (HTBA) has chosen Abolis as their partner to develop strains to produce valuable polyphenols, addressing supply chain challenges and driving innovation in the industry. Founded in 2019, after 40 years' experience under different ownership,...
2024-05-14 20:00
1796
HUB Organoids B.V. Awarded Frost & Sullivan's 2024 Technology Innovation Leadership Award for Transforming Drug Development with Highly Advanced Organoid Technology
HUB Organoids Holdings B.V. revolutionizes pre-clinical and clinical drug development through its cutting-edge organoid technology, enhancing its accuracy and efficiency. SAN ANTONIO, May 14, 2024 /PRNewswire/ -- Frost & Sullivan recently researched the organoids landscape and, based on its find...
2024-05-14 20:00
1593
Allozymes Raises $15 Million in Series A Funding, Poised to Revolutionize Industries with Enzymatic Solutions
SINGAPORE, May 14, 2024 /PRNewswire/ -- Allozymes, a leading innovator in enzyme discovery and engineering, today announced the closing of a$15 million Series A funding round led by Seventure Partners ofFrance and Xora Innovation of Singapore. This significant investment underscores the growing re...
2024-05-14 11:24
2147
Brii Biosciences Announces Two Breakthrough Therapy Designations for BRII-877 and BRII-835 Building on Extensive Clinical Evidence from Multiple Phase 2 Studies
DURHAM, N.C. and BEIJING, May 14, 2024 /PRNewswire/ -- Brii Biosciences Limited
2024-05-14 07:27
2144
Mabwell Announces Clinical Trial Progress of 9MW2821 in Triple-Negative Breast Cancer
SHANGHAI, May 13, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced the progress of the clinical study of its novel Nectin-4-targeting ADC (R&D code: 9MW2821) for triple-negative breast cancer. Based on 9MW2821's curren...
2024-05-13 22:00
1793
SK chemicals Targets the North American market with Circular Recycling Technology participating in NPE 2024
* Exhibition of circular recycled materials and waste plastic recycling comprehensive solutions * "We will further accelerate our expansion into North America by strengthening brand owner marketing." ORLANDO, Fla. and SEONGNAM, South Korea, May 13, 2024 /PRNewswire/ -- Following Chinaplas las...
2024-05-13 21:00
2439
BGI-HL OHA Lab inaugurated in Harbin, initiating colorectal cancer risk assessment for 800,000
SHENZHEN, China, May 13, 2024 /PRNewswire/ -- On May 10, 2024, the BGI-Heilongjiang Omics Health Axis Intelligent Laboratory (BGI-HL OHA Intelligent Laboratory) was inaugurated inHarbin, Heilongjiang province, China, marking a significant advance in the province's efforts to address public healt...
2024-05-13 13:34
1927
SCG Cell Therapy Presented New Preclinical Data in an Oral Presentation at ASGCT 2024 Annual Meeting Highlighting Superior Tumor Inhibition of its Immunoswitch Armored HPV-TCR T Cell Therapy (SCG142) against a Broad Range of HPV-associated Cancers
SINGAPORE, May 13, 2024 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, announced first preclinical data of its novel human papillomavirus (HPV)-specific T cell receptor-...
2024-05-13 10:00
3205
Caliway to Present the Latest Clinical Advancements at 2024 BIO International Convention
NEW TAIPEI CITY, May 11, 2024 /PRNewswire/ -- Caliway Biopharmaceuticals (Caliway) is pleased to announce its participation to share the latest clinical advancements at the upcoming 2024 BIO International Convention onWednesday, June 5th, at 11:45 a.m. PDT. The presentation will take place in Com...
2024-05-11 15:14
3297
Ribobay Pharma boosts CRDMO offerings with Cytiva's first FlexFactory platform for oligonucleotides
* FlexFactory platform for oligonucleotides, an integrated solution to boost efficiency and speed of pharmaceutical manufacturing to meet market demand SHANGHAI, May 10, 2024 /PRNewswire/ -- Ribobay Pharma, a leading Chinese biopharmaceutical contract research, development, and manufacturing o...
2024-05-10 18:39
2217
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Strategic Forum in Chongqing Drives Expansion of New Western Land-Sea Corridor
2024-11-16 14:15
5216
